scholarly journals Monitoring the antimicrobial activity of antiseptic eye drops

2019 ◽  
Vol 12 (3) ◽  
pp. 67-74 ◽  
Author(s):  
Igor N. Okolov
Keyword(s):  
Antimicrobial Activity ◽  
Inflammatory Diseases ◽  
Eye Drops ◽  
Bacterial Conjunctivitis ◽  
Gram Positive ◽  
Important Place ◽  
Treatment And Prevention ◽  
Ocular Infections ◽  
Clinically Significant ◽  
Gram Positive Cocci

Introduction. Antiseptic drugs currently occupy an important place in the treatment and prevention of ocular infectious and inflammatory diseases. Often microorganisms are characterized not only by resistance to a single antibiotic, but also by the presence of multiple resistances, which limits the choice of an effective drug. This problem requires a detailed study and monitoring of the sensitivity of the main pathogens of ocular infections, not only to antibiotics but also to antiseptics. The aim was to study the species composition of conjunctival microflora in patients with ocular surface infection and to evaluate the antimicrobial activity of antiseptic eye drops. Materials and methods. Investigation was carried out in 20122018 in 4237 bacterial conjunctivitis patients. The sensitivity to antiseptic preparations of pathogens isolated from patients with conjunctivitis was detected. Results. 1068 strains of microorganisms isolated from the conjunctival cavity of patients were tested. Gram-positive cocci dominated among clinically significant pathogens 47.4%. Antimicrobial activity of Vitabact eye drops against gram-positive cocci was higher than that of antiseptic Okomistin. Summary. Antimicrobial activity of the studied antiseptics against gram-positive and gram-negative pathogens was different. It is necessary to conduct further research on the antimicrobial activity of antiseptic eye drops.

Characteristics of the etiological structure and susceptibility to antibiotics, antiseptics of infectious pathogens of respiratory organs in children in critical states

2018 ◽  
Vol 22 (2) ◽  
pp. 311-317
Author(s):  
O.A. Nazarchuk ◽  
A.I. Starodub ◽  
O.V. Rymsha ◽  
V.A. Starodub ◽  
S.A. Kolodii
Keyword(s):  
Antimicrobial Activity ◽  
Antibacterial Agents ◽  
Inflammatory Diseases ◽  
Diffusion Method ◽  
Chlorhexidine Digluconate ◽  
Gram Positive ◽  
Critical States ◽  
Results Of Treatment ◽  
Moderate Resistance ◽  
Staphylococcus Spp

The study of the etiological structure, the properties of pathogens of the respiratory infectious diseases in children and their resistance to antibacterial agents is particularly relevant in modern conditions, expands the search for new approaches to combating pathogens, improves the results of treatment and reduces the mortality of this pathology. The aim — study of etiological structure, sensitivity to antibiotics and antiseptics of pathogens of infectious and inflammatory diseases of respiratory organs in children. In the study there were enrolled 247 patients who were treated in Vinnytsia Regional Children’s Clinical Hospital (VRCCH) in 2016. The sensitivity of microorganisms to 23 antibacterial agents was determined by the disc-diffusion method according to the generally accepted method. The analysis of the antimicrobial activity of antiseptic drugs (decamethoxine, miramistin, chlorhexidine digluconate) was performed by a double serial dilution technique with the determination of the minimum inhibitory bacteriostatic (MIC) and bactericidal (MBcC) concentrations, by the method of successive serial dilutions of the drug in a liquid nutrient medium. In patients who were in inpatient treatment at the VRCCH in 2016 because of pneumonia there were found opportunistic microorganisms which were of etiological significance in the development of the infection. Among them there were Streptococci (47,3 %), Staphylococci (15,3 %), Candida (13,3 %), Enterococci (10,9 %), including a high proportion of owned non-fermenting gram negative bacilli (9,8%) and species of Enterobacteria (2,0 %). Isolated strains of microorganisms had moderate resistance to most modern antibiotic drugs. The sensitivity of isolated strains of microorganisms to reserved antibiotics as carbapenems, often being used in the treatment of critical states of patients in the intensive care units, was found to above 18,2%. The sensitivity to this antibiotic in Enterococcus spp. (7,1 %), Staphylococcus spp. (5,9 %) was also low. Carbapenems, fluoroquinolones (the 1st and 2nd generations), antibiotics and aminoglycosides were found to be effective against gram positive microorganisms in more then 45% of cases. According to this they were considered to be as drugs of choice in the treatment of infectious and purulent-inflammatory pathology of respiratory organs, caused metitcilin- and vancomycin-resistant strains of microorganisms. Resistance to these drugs among investigated strains did not exceed 9,0 %. The high bactericidal properties of antiseptics as decamethoxine was determined against S.pyogenes, Staphylococcus spp. Its MBcC against these bacteria (1,65±0,20 mkg/ml and 4,32±0,50 mkg/ml, respectively) proved the advantage of decamethoxine’s effectiveness in comparison with chlorhexidine digluconate 3,14 times, 2,44 times miramistin. Clinical strains of C.albicans showed the highest susceptibility to decamethoxine, which fungicidal activity was determined in the presence (16,17±2,33 mkg/ml), in comparison with chlorxedine (MFtsK 27,59±3,59 mg/ml) and miramistin activity (27,59±3,595 mkg/ml). In children with inflammatory diseases of the respiratory organs gram-positive cocci are among the predominant pathogens (73,5 %) of cases, in the association allocated – 8,0 % of pathogens. Allocated strains of microorganisms were moderately resistant to all antibiotics studied. For antimicrobial activity antiseptic drugs, especially decamethoxine, have advantages over antibiotics confirming the possibility of their use in combination with systemic antibacterials.

scholarly journals A European Perspective on Topical Ophthalmic Antibiotics: Current and Evolving Options

2011 ◽  
Vol 3 ◽  
pp. OED.S4866 ◽  
Author(s):  
D. Bremond-Gignac ◽  
F. Chiambaretta ◽  
S. Milazzo
Keyword(s):  
Bacterial Infections ◽  
Treatment Options ◽  
Anterior Segment ◽  
Eye Drops ◽  
Short Treatment ◽  
Eye Infections ◽  
Perioperative Prophylaxis ◽  
Treatment And Prevention ◽  
Ocular Infections ◽  
Comprehensive Search

Background Eye infections can be vision-threatening and must be treated effectively by appropriate and safe use of topical ophthalmic anti-infectives. This review will essentially consider the current and evolving treatment options for the various types of bacterial eye infections. Ocular surface bacterial infections affect subjects of all ages with a high frequency in newborns and children. Methods This article presents a review of the peer-reviewed published scientific literature in order to define the well-established uses of anti-infective eye drops in the field of ocular infections. A comprehensive search of the recent published literature including topical ophthalmic anti-infectives effective in bacterial ocular infections was performed. Clinical studies provide relevant data concerning the characteristics and clinical efficacy of antibacterial eye drops in ocular anterior segment infections or for perioperative prophylaxis. Publications were included to cover the current options of antibacterial eye drops available in Europe. Results Several recent publications identified effective topical ocular antibacterials requiring a reduced dose regimen and a short treatment course. Additional literature reviewed included data on novel perioperative prophylaxis, indications for topical fortified antibiotics and innovative research including the risk of resistance. Conclusions Safe and effective topical antibiotic eye drops for the treatment and prevention of ocular infections must be adapted to the type of bacteria suspected. Usual topical antimicrobials should be replaced by more recent and more effective treatments. The use of highly effective fluoroquinolones should be reserved for the most severe cases to avoid resistance. Short treatment courses, such as azithromycin, can be easily used in children, thereby improving quality of life.

scholarly journals Modern opportunities for the prevention and treatment of inflammatory eye diseases of an infectious nature in children

2020 ◽  
Vol 12 (4) ◽  
pp. 57-65
Author(s):  
Vladimir V. Brzheskiy
Keyword(s):  
Surgical Procedures ◽  
Inflammatory Diseases ◽  
Infectious Complications ◽  
Eye Diseases ◽  
Eye Drops ◽  
High Efficacy ◽  
Bacterial Conjunctivitis ◽  
Perioperative Prophylaxis ◽  
Prevention And Treatment ◽  
Chronic Conjunctivitis

The development of inflammatory diseases of the cornea and conjunctiva, as well as the occurrence of infectious complications of intraocular surgery, are largely associated with the presence of saprophytic and pathogenic microflora in the conjunctival cavity. This circumstance is more characteristic of children. At the same time, the possibilities of antibacterial therapy of inflammatory eye diseases of bacterial and chlamydial etiology, as well as perioperative prophylaxis of infectious complications of intraocular surgical procedures in children, have significantly expanded today. The widespread use of fluoroquinolones has significantly improved the treatment of children with acute and chronic bacterial conjunctivitis, keratitis, blepharitis, meibomyitis, chalazion, as well as those with chronic conjunctivitis of chlamydial etiology. At the same time, levofloxacin fluoroquinolone of the 3rd generation, which is used in our country in the form of a 0.5% solution as eye drops Oftaquix (Santen, Finland), has demonstrated high efficacy for this purpose. The widespread introduction of the original 0.5% levofloxacin (Oftaquix), in the treatment regimen for children with inflammatory diseases of the cornea and conjunctiva, as well as for a perioperative prevention of infectious complications of surgical procedures involving them, is a promising way to solve the problem.

scholarly journals ETIOLOGICAL STRUCTURE OF MICROBIOTA IN ODONTOGENIC INFECTIOUS INFLAMMATORY DISEASES OF MAXILLOFACIAL AREA

2020 ◽  
Vol 20 (3) ◽  
pp. 217-221
Author(s):  
M.O. Faustova
Keyword(s):  
Inflammatory Diseases ◽  
Infectious Complications ◽  
Surgical Patients ◽  
Gram Negative Bacteria ◽  
Gram Positive ◽  
Gram Negative ◽  
Infectious Process ◽  
Causative Agents ◽  
Gram Positive Cocci ◽  
Selection Of

In recent decades, the etiological structure of infectious complications in surgery has remained almost unchanged. The aim of this study is to identify the leading pathogens of odontogenic infectious and inflammatory diseases of the maxillofacial area in patients. Materials and methods. The study involved 137 patients with odontogenic infectious and inflammatory diseases of the maxillofacial area. The final species identification of microorganisms was performed according to the generally accepted method. Results. 117 clinical strains of microorganisms were isolated from patients and identified. It was found the most common causative agents of odontogenic infectious and inflammatory diseases of the maxillofacial area in patients were gram-positive cocci. It should be noted that the vast majority of isolates were members of the genus Staphylococcus. Gram-negative microorganisms were detected in patients much less frequently (31.6%) compared with gram-positive. In 5.1% of case, C. albicans acted as the dominant pathogen in the material taken from patients with purulent diseases. It was found out that during the development of the abscess, the microbiota were more diverse, but the percentage of pathogens differed significantly with the selection of S. aureus, A. baumannii and E. faecalis as the main ones. In turn, with the aggravation of the infectious process and the development of phlegmon and mediastinitis in patients, a decrease in the spectrum of microorganisms in the studied materials was observed, along with an increase in their percentages. Conclusions. The etiological structure of microbiota of odontogenic infectious-inflammatory diseases of the maxillofacial area is predominantly represented by opportunistic microorganisms of the genera Staphylococcus, Enterococcus, Acinetobacter and Pseudomonas. In general, gram-positive cocci and non-fermenting gram-negative bacteria are the dominant causative agents of odontogenic infectious-inflammatory diseases of the maxillofacial area in most surgical patients.

Antimicrobial Activity of Gatifloxacin Tested Against 1676 Gram-Positive Cocci Resistant to Ciprofloxacin

Drugs ◽  
1999 ◽  
Vol 58 (Supplement 2) ◽  
pp. 162-163 ◽  
Author(s):  
RN Jones ◽  
MA Pfaller ◽  
GV Doern ◽  
M Beach
Keyword(s):  
Antimicrobial Activity ◽  
Gram Positive ◽  
Gram Positive Cocci

scholarly journals Glycopeptide Resistance in Gram-Positive Cocci: A Review

2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
S. Sujatha ◽  
Ira Praharaj
Keyword(s):  
Vancomycin Resistance ◽  
Coagulase Negative Staphylococci ◽  
Glycopeptide Resistance ◽  
Gram Positive ◽  
Nosocomial Pathogens ◽  
Gram Positive Bacteria ◽  
Serious Infections ◽  
Vancomycin Resistant ◽  
Clinically Significant ◽  
Gram Positive Cocci

Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens in the past two decades all over the world and have seriously limited the choices available to clinicians for treating infections caused by these agents. Methicillin-resistantStaphylococcus aureus, perhaps the most notorious among the nosocomial pathogens, was till recently susceptible to vancomycin and the other glycopeptides. Emergence of vancomycin nonsusceptible strains ofS. aureushas led to a worrisome scenario where the options available for treating serious infections due to these organisms are very limited and not well evaluated. Vancomycin resistance in clinically significant isolates of coagulase-negative staphylococci is also on the rise in many setups. This paper aims to highlight the genetic basis of vancomycin resistance inEnterococcusspecies andS. aureus. It also focuses on important considerations in detection of vancomycin resistance in these gram-positive bacteria. The problem of glycopeptide resistance in clinical isolates of coagulase-negative staphylococci and the phenomenon of vancomycin tolerance seen in some strains ofStreptococcus pneumoniaehas also been discussed. Finally, therapeutic options available and being developed against these pathogens have also found a mention.

Sign in / Sign up

Export Citation Format

Share Document